Study of Prescribing Pattern, Identification of Drug Related Problems and Therapeutic Intervention in Cardio Vascular Diseases (CVD) Patients
Abstract
Cardiovascular disease (CVD) is a disorder of heart and blood vessels. CVD is one of the major causes of deaths in India, which contributed around 30 to 40%. The aim of the study was to study the prescribing pattern of drugs, identification of drug related problems and therapeutic intervention in CVD patients. A hospital based prospective and observational study was carried out for a period of nine months in a south Indian tertiary care hospital. Among 120 selected patients, 79 were male (65.83%) and 41 were female (34.16%), more number of patients (35) were between the age group of 55-64 (29.16%) of which 27 were males & 8 were females, and very less number of patients (6) were between the age group 85-94 (5%) of which all the 6 were male. Hypertension is the most commonest and dominant disorder, which affected 47(39.16%) patients, in which 30 were male (25%) and 17 were female (14.16%). Most common risk factor is HTN followed with smoking and diabetes of 45 patients (37.5%). The most often prescribed pattern adopted in CVD is Dual therapy, it is most frequently used therapy 50 (41.66%) and quadruple therapy is less frequently 6(6.5%) used. The diuretics and calcium channel blocker combination were maximally prescribed class of drugs as a dual therapy. A total of 47 drug-drug interactions were found, among 12 were major, 15 were moderate and 20 were minor interactions. Clinical pharmacist has intervened with the help of other health care professionals in order to reduce the risk factor and minimise the drug-drug interactions. The study provides the benefits of presence of clinical pharmacist in a hospital setting, in order to prevent the medication related errors and provide the expertise pharmacotherapy opinion in CVD patients, which improves the patient compliance. Hence study justifies a need of active collaboration between clinical pharmacist, physician and other health care professionals for the better management of CVD patients.
Keywords: Prescribing Pattern; Cardio Vascular Diseases; Drug Related Problems; Therapeutic Intervention.
DOI
https://doi.org/10.22270/jddt.v8i6-s.2088References
Muhit M.A, Rahman M.O, Raihan S.Z, Asaduzzaman M, Akbar M.A, NahidSharmin. et. al. Cardiovascular disease prevalence and prescription patterns at a tertiary level hospital in Bangladesh.J App Pharm Sci. 2012; 02(03):80-4.
Trick WE, Scheckler WE, Tokars JI, Jones KC, Reppen ML, Smith EM and Jarvis WR. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2000; 119(1):108-14.
https://www.medicalnewstoday.com/articles/257484.php
Koch-Weser J. The therapeutic challenge of systolic hypertension. N Engl J Med. 1973; 289:481-2.
https://www.nhs.uk/conditions/coronary-heart-disease/diagnosis/
Nanda A. MedScape [Internet]. [place unknown]. [publisher unknown]. [Dec 01, 2015]. Available from: http://emedicine.medscape.com/article/1910519-overview.
Zodda D, Giammona R, Schifilliti S. Treatment strategy for dyslipidemia in cardiovascular disease prevention: Focus on old and new drugs. Pharmacy. 2017; 6(10):1-16.
Jason M. Tarkin, Juan C Kaski. Vasodilator therapy: Nitrates and Nicorandil. Springer Open Choice.2016; 30(4):367-378.
https://www.webmd.com/hypertension-high-blood-pressure/guide/treatment-angiotensin-ii
https://www.healthline.com/health/diuretics.
Goerler H, Simon A et al., The journal of thoracic and cardiovascular surgery. Elsevier.2010; 140(2):433-439.
Tanuseputro P, Manuel DG, Leung M et.al.,Risk factors for cardiovascular disease in cannada. Can J Cardiol. 2003; 19(11):1249-1259.
Olusegun A B, Oluyonbo R, Segun Matthew A et.al.,Prescribing pattern and utilization of anti-hypertensive drugs and blood pressure control in adult patients with systemic hypertension in a rural teritiary hospital in Nigeria. American journal of internal medicine. 2014; 2(6):144-149
Published
Abstract Display: 1014 
PDF Downloads: 771 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.